Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
AST SpaceMobile
ASTS
$17.6B
| $689K | ﹤0.01% |
146,562
-11,165
| -7% | -$57.9K |
|
4252
CALL
Penumbra
PEN
$12.7B
| $688K | ﹤0.01% |
2,000
-29,400
| -94% | -$9.03M |
|
4253
Vera Bradley
VRA
$97M
| $687K | ﹤0.01% |
107,552
-273,363
| -72% | -$1.54M |
|
4254
BlueLinx
BXC
$422M
| $686K | ﹤0.01% |
7,311
+2,985
| +69% | +$239K |
|
4255
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.65B
| $686K | ﹤0.01% |
5,321
-22,737
| -81% | -$2.85M |
|
4256
CALL
Louisiana-Pacific
LPX
$5.06B
| $682K | ﹤0.01% |
+9,100
| New | +$563K |
|
4257
PUT
BioNTech
BNTX
$22.9B
| $680K | ﹤0.01% |
+6,300
| New | +$709K |
|
4258
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $679K | ﹤0.01% |
23,069
-131,449
| -85% | -$3.88M |
|
4259
Graham Corp
GHM
$1.12B
| $678K | ﹤0.01% |
51,076
-12,083
| -19% | -$152K |
|
|
CTRA
4260
PUT
DELISTED
Coterra Energy
CTRA
| $678K | ﹤0.01% |
+26,800
| New | +$666K |
|
4261
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
| $678K | ﹤0.01% |
13,400
+5,400
| +68% | +$274K |
|
|
JWN
4262
CALL
DELISTED
Nordstrom
JWN
| $678K | ﹤0.01% |
33,100
-26,000
| -44% | -$437K |
|
4263
Cytosorbents Corp
CTSO
$22.7M
| $676K | ﹤0.01% |
188,389
-10,158
| -5% | -$32.1K |
|
4264
Euroseas
ESEA
$557M
| $675K | ﹤0.01% |
+38,274
| New | +$626K |
|
4265
LCI Industries
LCII
$2.49B
| $675K | ﹤0.01% |
5,338
-5,516
| -51% | -$632K |
|
4266
CALL
Planet Fitness
PLNT
$4.42B
| $674K | ﹤0.01% |
+10,000
| New | +$717K |
|
4267
CALL
Agilon Health
AGL
$1.53B
| $673K | ﹤0.01% |
1,552
-3,432
| -69% | -$1.93M |
|
4268
Vanguard Russell 1000 Growth ETF
VONG
$42.8B
| $673K | ﹤0.01% |
+9,506
| New | +$622K |
|
4269
CALL
Adaptive Biotechnologies
ADPT
$3.59B
| $671K | ﹤0.01% |
100,000
-70,000
| -41% | -$520K |
|
|
EQC
4270
DELISTED
Equity Commonwealth
EQC
| $670K | ﹤0.01% |
33,091
-222,359
| -87% | -$4.6M |
|
|
STER
4271
DELISTED
Sterling Check Corp. Common Stock
STER
| $670K | ﹤0.01% |
+54,637
| New | +$655K |
|
|
ADAM
4272
Adamas Trust
ADAM
$815M
| $668K | ﹤0.01% |
67,384
+47,727
| +243% | +$474K |
|
4273
Waterstone Financial
WSBF
$370M
| $664K | ﹤0.01% |
45,836
+30,546
| +200% | +$436K |
|
|
TELL
4274
DELISTED
Tellurian Inc.
TELL
| $664K | ﹤0.01% |
470,936
-975,844
| -67% | -$1.31M |
|
4275
Lyell Immunopharma
LYEL
$317M
| $664K | ﹤0.01% |
10,434
-6,864
| -40% | -$380K |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.